Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...

During the restructuring process, 23andMe obtained up to $35 million in debtor-in-possession finance to assist operations as ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

New York Attorney General Letitia James on Tuesday urged 23andMe customers to delete their accounts and secure their data, ...

Under the deal, Sensodyne maker Haleon has agreed to buy back 44 million shares from Pfizer, currently its largest ...

Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer healthcare company. The American pharma giant announced on ...

Operating a genetic testing business is difficult. Plus, YouTube has become the biggest platform for podcast consumption.

After 23andMe announced that it’s headed to bankruptcy court, it’s unclear what happens to the mass of sensitive genetic data ...

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...

Pfizer has fully exited its investment in UK-listed pharma group Haleon, selling off its remaining 7.3% stake for £2.5bn.

Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.

Me’s weekend bankruptcy filing has ignited concerns among consumers who provided the company with their genetic information, and reignited discussions on data privacy among policymakers and se | ...